Lima Memorial Health System Logo
Approximate ER WAIT TIME
5

Health Library

Chediak-Higashi syndrome
Site Map

Chediak-Higashi syndrome

Chediak-Higashi syndrome is a rare disease of the immune and nervous systems. It involves pale-colored hair, eyes, and skin.

I Would Like to Learn About:

Causes

Chediak-Higashi syndrome is passed down through families (inherited). It is an autosomal recessive disease. This means that both parents are carriers of a non-working copy of the gene. Each parent must pass their non-working gene to the child for them to show symptoms of the disease.

Defects have been found in the LYST (also called CHS1) gene. The primary defect in this disease is found in certain substances normally present in skin cells and certain white blood cells.

Symptoms

Children with this condition may have:

  • Silver hair, light-colored eyes (albinism)
  • Increased infections in the lungs, skin, and mucous membranes
  • Jerky eye movements (nystagmus)

Infection of affected children with certain viruses, such as Epstein-Barr virus (EBV), can cause a life-threatening illness resembling the blood cancer lymphoma.

Other symptoms may include:

  • Decreased vision
  • Intellectual disability
  • Muscle weakness
  • Nerve problems in the limbs (peripheral neuropathy)
  • Nosebleeds or easy bruising
  • Numbness
  • Tremor
  • Seizures
  • Sensitivity to bright light (photophobia)
  • Unsteady walking (ataxia)

Exams and Tests

The health care provider will perform a physical exam. This may show signs of a swollen spleen or liver or jaundice.

Tests that may be done include:

  • Complete blood count, including white blood cell count
  • Blood platelet count
  • Blood culture and smear
  • Brain MRI or CT
  • EEG
  • EMG
  • Nerve conduction tests

Treatment

There is no specific treatment for Chediak-Higashi syndrome. Bone marrow transplants performed early in the disease appear to have been successful in several patients.

Antibiotics are used to treat infections. Antiviral drugs, such as acyclovir, and chemotherapy drugs are often used in the accelerated phase of the disease. Blood and platelet transfusions are given as needed. Surgery may be needed to drain abscesses in some cases.

Support Groups

National Organization for Rare Disorders (NORD) -- rarediseases.org/rare-diseases/chediak-higashi-syndrome/

Outlook (Prognosis)

Death often occurs in the first 10 years of life, from long-term (chronic) infections or accelerated disease that results in lymphoma-like illness. However, some affected children have survived longer.

Possible Complications

Complications may include:

  • Frequent infections involving certain types of bacteria
  • Lymphoma-like cancer triggered by viral infections such as EBV
  • Early death

When to Contact a Medical Professional

Contact your provider if you have a family history of this disorder and you are planning to have children.

Talk to your provider if your child shows symptoms of Chediak-Higashi syndrome.

Prevention

Genetic counseling is recommended before becoming pregnant if you have a family history of Chediak-Higashi syndrome.

Related Information

Autosomal recessive
Albinism
Nystagmus
Movement - uncoordinated
Peripheral neuropathy
Mononucleosis
Hodgkin lymphoma

References

Coates TD. Disorders of phagocyte function. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 156.

Dinauer MC, Coates TD. Disorders of phagocyte function. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 7th ed. Philadelphia, PA: Elsevier; 2018:chap 50.

Toro C, Nicoli ER, Malicdan MC, et al. Chediak-Higashi syndrome. Gene Reviews [Internet]. 2015. PMID: 20301751 pubmed.ncbi.nlm.nih.gov/20301751/. Updated July 5, 2018. Accessed October 29, 2021.

BACK TO TOP

Review Date: 7/30/2021  

Reviewed By: Anna C. Edens Hurst, MD, MS, Associate Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2022 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.